DUBLIN--(BUSINESS WIRE)--The "Data Integrity by Design and Pharma 4.0: Next-Gen Techniques to Approach GxP Systems, and FDA Compliance" training has been added to ResearchAndMarkets.com's offering.
AI and accelerated computing are transforming the bio/pharmaceutical sector by addressing organizational, technological, and ...
ACD/Labs updates Katalyst D2D with new automation, data integration and workflow tools to speed drug development.
Eva-Maria Hempe, NVIDIA, says bio/pharma must centralize AI strategy, tackle silos, prioritize process integrity, and balance quick wins with long-term drug design goals.
Modern laboratories in quality control need solutions that ensure precise analysis, lasting reliability, and secure digital ...
Data integrity is an ongoing concern across all R&D organizations, no matter what part of the research lifecycle they’re navigating. These concerns extend beyond the potential for delayed timelines or ...
As direct-to-patient deliveries of temperature-sensitive medications rise, the pharmaceutical industry is racing to protect ...
After misconduct at a key trial site raised questions of data integrity earlier this year, BioXcel Therapeutics’ Alzheimer’s agitation prospect faced a grim outlook. Now, with a third-party audit in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback